Participant flow16

How many started, completed or left each group, period by period.

1 to 16 of 16

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	189
Overall Study	STARTED	Pregabalin 300 mg	187
Overall Study	STARTED	Pregabalin 450 mg	184
Overall Study	STARTED	Pregabalin 600 mg	187
Overall Study	TREATED	Placebo	184
Overall Study	TREATED	Pregabalin 300 mg	184
Overall Study	TREATED	Pregabalin 450 mg	182
Overall Study	TREATED	Pregabalin 600 mg	186
Overall Study	COMPLETED	Placebo	141
Overall Study	COMPLETED	Pregabalin 300 mg	123
Overall Study	COMPLETED	Pregabalin 450 mg	133
Overall Study	COMPLETED	Pregabalin 600 mg	121
Overall Study	NOT COMPLETED	Placebo	48
Overall Study	NOT COMPLETED	Pregabalin 300 mg	64
Overall Study	NOT COMPLETED	Pregabalin 450 mg	51
Overall Study	NOT COMPLETED	Pregabalin 600 mg	66

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00333866/flow